{
    "title": "HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children",
    "pmid": "23588310",
    "pmcid": "PMC3839910",
    "study_parameters": [
        {
            "Study Parameters ID": 994166721,
            "Variant Annotation ID": 994166507,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.002",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 38.6,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "994166507"
        },
        {
            "Study Parameters ID": 994531644,
            "Variant Annotation ID": 994531642,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 1.0",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.09,
            "Confidence Interval Start": 0.04,
            "Confidence Interval Stop": 27.5,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "994531642"
        },
        {
            "Study Parameters ID": 993944507,
            "Variant Annotation ID": 993944301,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 1.0",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.33,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "993944301"
        },
        {
            "Study Parameters ID": 993818102,
            "Variant Annotation ID": 993813998,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.0037",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 8.6,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "993813998"
        },
        {
            "Study Parameters ID": 993728141,
            "Variant Annotation ID": 992282434,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.0025",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 26.4,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "992282434"
        },
        {
            "Study Parameters ID": 994398281,
            "Variant Annotation ID": 994398056,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 1.0",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 4.44,
            "Confidence Interval Start": 0.16,
            "Confidence Interval Stop": 120.0,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "994398056"
        }
    ],
    "var_drug_ann": [],
    "var_pheno_ann": [
        {
            "Variant Annotation ID": 994166507,
            "Variant/Haplotypes": "HLA-B*15:02",
            "Gene": "HLA-B",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "HLA-B *15:02 is associated with increased risk of Stevens-Johnson Syndrome when treated with carbamazepine in children.",
            "Alleles": "*15:02",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Stevens-Johnson Syndrome",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "994166507"
        },
        {
            "Variant Annotation ID": 994531642,
            "Variant/Haplotypes": "HLA-B*15:02",
            "Gene": "HLA-B",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": null,
            "Sentence": "HLA-B *15:02 is not associated with increased risk of Maculopapular Exanthema when treated with carbamazepine in children.",
            "Alleles": "*15:02",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Maculopapular Exanthema",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "994531642"
        },
        {
            "Variant Annotation ID": 993944301,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": null,
            "Sentence": "HLA-A *31:01 is not associated with increased risk of Stevens-Johnson Syndrome when treated with carbamazepine in children.",
            "Alleles": "*31:01",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Stevens-Johnson Syndrome",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "993944301"
        },
        {
            "Variant Annotation ID": 993813998,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "HLA-A *31:01 is associated with increased risk of Maculopapular Exanthema when treated with carbamazepine in children.",
            "Alleles": "*31:01",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Maculopapular Exanthema",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "993813998"
        },
        {
            "Variant Annotation ID": 992282434,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "HLA-A *31:01 is associated with increased risk of Carbamazepine-induced hypersensitivity syndrome when treated with carbamazepine in children.",
            "Alleles": "*31:01",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Carbamazepine-induced hypersensitivity syndrome",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "992282434"
        },
        {
            "Variant Annotation ID": 994398056,
            "Variant/Haplotypes": "HLA-B*15:02",
            "Gene": "HLA-B",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": null,
            "Sentence": "HLA-B *15:02 is not associated with increased risk of Carbamazepine-induced hypersensitivity syndrome (HSS) when treated with carbamazepine in children.",
            "Alleles": "*15:02",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Carbamazepine-induced hypersensitivity syndrome (HSS)",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "994398056"
        }
    ],
    "var_fa_ann": []
}